We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.50 | 4.86% | 97.00 | 90.00 | 100.00 | 95.00 | 92.50 | 92.50 | 18,552 | 16:35:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 24k | -17.01M | -0.2722 | -3.49 | 59.35M |
Hot Features
Premium
RNS Number:3554O
Celsis International PLC
05 August 2003
Celsis International PLC (the "Company")
Notification of Major Interests in Shares
The Company received a notification today from M & G Investment Management
Limited, informing them that they have a notifiable interest in 4,200,000
ordinary shares, representing 3.93% of the issued ordinary share capital of the
Company.
5 August, 2003
Contact;
Jenny Parsons
Celsis International PLC
01638 600151
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVSVROWRWRAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
